Breaking
Who am I? Plus today's other quizzes Roast chicken, congee and cookies: Ravinder Bhogal’s autumn squash recipes LIV Golf secures potential $300m investment Nobel prize in physics goes to Francis Halzen for south pole work on neutrinos Gassiev unsure if Fury v Joshua will be for his WBA belt Stop worrying about my AI, says multibillionaire Sam Altman. So we bear the risks and he keeps the money | Chris Stokel-Walker Cristiano Ronaldo accuses Portugal coach Jorge Jesus of broken promises How AI decision models could change content moderation Republican John James seeks some distance from Trump in Michigan governor debate Battle of ideas looming in British politics, Badenoch to say
NEWSREEL
The day, in 30-second reels.
--:--:--
Science / Reel
Science · Video brief

US man posed as doctor in scheme to profit from Ozempic, prosecutors say

An Illinois man, Rodney Greer, faces serious charges for impersonating doctors to profit from Ozempic prescriptions. He allegedly used personal info from 60 doctors across 19 states, contacting over 3,300 pharmacies to secure unauthorized p...

The Guardian· Aug 18, 2026 · 9:42 PM · 45 views

Video won't play? Watch on YouTube →

An Illinois man, Rodney Greer, faces serious charges for impersonating doctors to profit from Ozempic prescriptions. He allegedly used personal info from 60 doctors across 19 states, contacting over 3,300 pharmacies to secure unauthorized prescriptions for weight loss drugs.

Full story and more reels: https://newsreel.video

#news #breaking #healthcare #fraud #Ozempic #identitytheft #legalnews

Originally reported by The Guardian. Read the full story →

More in Science

Science Scien
Science

Nobel prize in physics goes to Francis Halzen for south pole work on neutrinos

The Guardian· 6 hours ago
Science Scien
Science

A nurse was attacked by ICE agents on camera. Now she wants justice – Stateside with Kai and Carter

The Guardian· 7 hours ago
Science Scien
Science

Nobel Prize in physics to be awarded in Stockholm

NBC News· 9 hours ago

0 Comments

No comments yet. Be the first.